Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06428396 |
| Title | Study of Belzutifan (MK-6482) Plus Fulvestrant for ER+/HER2- Metastatic Breast Cancer (MK-6482-029/LITESPARK-029) |
| Acronym | MK-6482-029/LITESPARK-029 |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Merck Sharp & Dohme LLC |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital ( Site 0011) | RECRUITING | Marietta | Georgia | 30060 | United States | Details |
| Renown Regional Medical Center ( Site 0018) | RECRUITING | Reno | Nevada | 89502 | United States | Details |
| Seoul National University Hospital ( Site 3100) | RECRUITING | Seoul | 03080 | Korea, Republic of | Details |